164 related articles for article (PubMed ID: 27799918)
1. Magnetoencephalography for the Detection of Intervention Effects of a Specific Nutrient Combination in Patients with Mild Alzheimer's Disease: Results from an Exploratory Double-Blind, Randomized, Controlled Study.
van Straaten EC; de Waal H; Lansbergen MM; Scheltens P; Maestu F; Nowak R; Hillebrand A; Stam CJ
Front Neurol; 2016; 7():161. PubMed ID: 27799918
[TBL] [Abstract][Full Text] [Related]
2. The effect of souvenaid on functional brain network organisation in patients with mild Alzheimer's disease: a randomised controlled study.
de Waal H; Stam CJ; Lansbergen MM; Wieggers RL; Kamphuis PJ; Scheltens P; Maestú F; van Straaten EC
PLoS One; 2014; 9(1):e86558. PubMed ID: 24475144
[TBL] [Abstract][Full Text] [Related]
3. Tolerability and safety of Souvenaid in patients with mild Alzheimer's disease: results of multi-center, 24-week, open-label extension study.
Olde Rikkert MG; Verhey FR; Blesa R; von Arnim CA; Bongers A; Harrison J; Sijben J; Scarpini E; Vandewoude MF; Vellas B; Witkamp R; Kamphuis PJ; Scheltens P
J Alzheimers Dis; 2015; 44(2):471-80. PubMed ID: 25322923
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of Souvenaid in mild Alzheimer's disease: results from a randomized, controlled trial.
Scheltens P; Twisk JW; Blesa R; Scarpini E; von Arnim CA; Bongers A; Harrison J; Swinkels SH; Stam CJ; de Waal H; Wurtman RJ; Wieggers RL; Vellas B; Kamphuis PJ
J Alzheimers Dis; 2012; 31(1):225-36. PubMed ID: 22766770
[TBL] [Abstract][Full Text] [Related]
5. The medical food Souvenaid affects brain phospholipid metabolism in mild Alzheimer's disease: results from a randomized controlled trial.
Rijpma A; van der Graaf M; Lansbergen MM; Meulenbroek O; Cetinyurek-Yavuz A; Sijben JW; Heerschap A; Olde Rikkert MGM
Alzheimers Res Ther; 2017 Jul; 9(1):51. PubMed ID: 28747210
[TBL] [Abstract][Full Text] [Related]
6. Exploring effects of Souvenaid on cerebral glucose metabolism in Alzheimer's disease.
Scheltens NME; Briels CT; Yaqub M; Barkhof F; Boellaard R; van der Flier WM; Schwarte LA; Teunissen CE; Attali A; Broersen LM; van Berckel BNM; Scheltens P
Alzheimers Dement (N Y); 2019; 5():492-500. PubMed ID: 31650005
[TBL] [Abstract][Full Text] [Related]
7. Design of the NL-ENIGMA study: Exploring the effect of Souvenaid on cerebral glucose metabolism in early Alzheimer's disease.
Scheltens NME; Kuyper IS; Boellaard R; Barkhof F; Teunissen CE; Broersen LM; Lansbergen MM; van der Flier WM; van Berckel BNM; Scheltens P
Alzheimers Dement (N Y); 2016 Nov; 2(4):233-240. PubMed ID: 29067310
[TBL] [Abstract][Full Text] [Related]
8. Nutritional approaches in the risk reduction and management of Alzheimer's disease.
Mi W; van Wijk N; Cansev M; Sijben JW; Kamphuis PJ
Nutrition; 2013 Sep; 29(9):1080-9. PubMed ID: 23756280
[TBL] [Abstract][Full Text] [Related]
9. The S-Connect study: results from a randomized, controlled trial of Souvenaid in mild-to-moderate Alzheimer's disease.
Shah RC; Kamphuis PJ; Leurgans S; Swinkels SH; Sadowsky CH; Bongers A; Rappaport SA; Quinn JF; Wieggers RL; Scheltens P; Bennett DA
Alzheimers Res Ther; 2013; 5(6):59. PubMed ID: 24280255
[TBL] [Abstract][Full Text] [Related]
10. Targeting synaptic dysfunction in Alzheimer's disease by administering a specific nutrient combination.
van Wijk N; Broersen LM; de Wilde MC; Hageman RJ; Groenendijk M; Sijben JW; Kamphuis PJ
J Alzheimers Dis; 2014; 38(3):459-79. PubMed ID: 23985420
[TBL] [Abstract][Full Text] [Related]
11. Souvenaid®: a new approach to management of early Alzheimer's disease.
Ritchie CW; Bajwa J; Coleman G; Hope K; Jones RW; Lawton M; Marven M; Passmore P
J Nutr Health Aging; 2014 Mar; 18(3):291-9. PubMed ID: 24626757
[TBL] [Abstract][Full Text] [Related]
12. Alzheimer's disease: The state of the art in resting-state magnetoencephalography.
Engels MMA; van der Flier WM; Stam CJ; Hillebrand A; Scheltens P; van Straaten ECW
Clin Neurophysiol; 2017 Aug; 128(8):1426-1437. PubMed ID: 28622527
[TBL] [Abstract][Full Text] [Related]
13. The LipiDiDiet trial: what does it add to the current evidence for Fortasyn Connect in early Alzheimer's disease?
Rasmussen J
Clin Interv Aging; 2019; 14():1481-1492. PubMed ID: 31616139
[TBL] [Abstract][Full Text] [Related]
14. Slowing of Hippocampal Activity Correlates with Cognitive Decline in Early Onset Alzheimer's Disease. An MEG Study with Virtual Electrodes.
Engels MM; Hillebrand A; van der Flier WM; Stam CJ; Scheltens P; van Straaten EC
Front Hum Neurosci; 2016; 10():238. PubMed ID: 27242496
[TBL] [Abstract][Full Text] [Related]
15. A Randomized, Double-Blind, Phase 2 Study of the Effects of the Vaccine Vanutide Cridificar with QS-21 Adjuvant on Immunogenicity, Safety and Amyloid Imaging in Patients with Mild to Moderate Alzheimer's Disease.
Ketter N; Liu E; Di J; Honig LS; Lu M; Novak G; Werth J; LePrince Leterme G; Shadman A; Brashear HR
J Prev Alzheimers Dis; 2016; 3(4):192-201. PubMed ID: 29199321
[TBL] [Abstract][Full Text] [Related]
16. Effect Size Analyses of Souvenaid in Patients with Alzheimer's Disease.
Cummings J; Scheltens P; McKeith I; Blesa R; Harrison JE; Bertolucci PH; Rockwood K; Wilkinson D; Wijker W; Bennett DA; Shah RC
J Alzheimers Dis; 2017; 55(3):1131-1139. PubMed ID: 27767993
[TBL] [Abstract][Full Text] [Related]
17. Utility of imaging for nutritional intervention studies in Alzheimer's disease.
de Wilde MC; Kamphuis PJ; Sijben JW; Scheltens P
Eur J Pharmacol; 2011 Sep; 668 Suppl 1():S59-69. PubMed ID: 21816137
[TBL] [Abstract][Full Text] [Related]
18. EEG-MEG Integration Enhances the Characterization of Functional and Effective Connectivity in the Resting State Network.
Muthuraman M; Moliadze V; Mideksa KG; Anwar AR; Stephani U; Deuschl G; Freitag CM; Siniatchkin M
PLoS One; 2015; 10(10):e0140832. PubMed ID: 26509448
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
